Modelling in Preclinical and Clinical Drug Development
Luc P. Balant, Marianne Gex‐Fabry · 2001
Research and development of new drug entities are becoming more complex with the advancement of basic sciences. At one end of the drug development process, computer-calculated structures of receptors are progressively used to design new chemical entities with specific pharmacological/therapeutic activities.